Clinical Trials on Experimental Tumor in Netherlands

Total 738 results

Novartis Pharmaceuticals

Completed

Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function

Advanced Solid Tumors

Switzerland, Netherlands, United States, United Kingdom
Merck Sharp & Dohme LLC

Recruiting

Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001)

Neoplasms | Advanced/Metastatic Solid Tumors

Canada, Israel, United States, Netherlands
Cristal Therapeutics

Completed

A Study of CriPec® Docetaxel Given to Patients With Solid Tumours (NAPOLY)

Cancer | Metastatic Cancer | Solid Tumors

Netherlands, Belgium
UMC Utrecht
Radboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaborators

Recruiting

Glioblastoma Targeted Treatment Option Maximization by WGS (GLOW)

Glioblastoma

Netherlands
Maastricht Radiation Oncology
Maastricht University Medical Center; Ziekenhuis Oost-Limburg; Zuyderland Medisch...

Active, not recruiting

A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors (HiLoGlio)

High Grade Glioma | Low-grade Glioma

Netherlands
Regeneron Pharmaceuticals
Sanofi

Completed

An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)

Melanoma

Korea, Republic of, Serbia, Netherlands, United Kingdom
University Medical Center Groningen

Terminated

Nivo/Ipi Combination Therapy in Symptomatic Brain Metastases (CA209-322)

Melanoma | Brain Metastasis

Netherlands
European Organisation for Research and Treatment...

Completed

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Sarcoma | Gastrointestinal Stromal Tumor

France, Netherlands, Belgium, United Kingdom, Germany
Erasmus Medical Center

Recruiting

Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma (PhysMRRT)

Glioblastoma

Netherlands
Leiden University Medical Center
Philips Healthcare; European Commission

Recruiting

Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors (A-IMAGIO)

Hepatocellular Carcinoma | Liver Metastases | Liver Cancer | Liver Metastasis Colon Cancer

Netherlands
Amsterdam UMC, location VUmc

Not yet recruiting

Reducing Cognitive Impairment in Glioma With Repetitive Transcranial Magnetic Stimulation and Cognitive Strategy Training (TRUE-GRIT)

Glioma | Cognitive Impairment

Netherlands
Erasmus Medical Center
Hospices Civils de Lyon; Maastro Clinic, The Netherlands

Recruiting

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors (INTHYM)

Thymic Carcinoma | Thymoma | Thymic Epithelial Tumor | Thymoma and Thymic Carcinoma

Netherlands
AstraZeneca

Completed

Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours

Tumors

Netherlands, Germany, United Kingdom
Leiden University Medical Center

Recruiting

PRolaCT - Three Prolactinoma RCTs

Prolactinoma | Prolactin-Producing Pituitary Tumor

Netherlands
UMC Utrecht
M.D. Anderson Cancer Center; Odense University Hospital; Radboud University Medical... and other collaborators

Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (MOMENTUM)

Neoplasms | Quality of Life | Breast Cancer | Head and Neck Cancer | Head and Neck Neoplasms | Gynecologic Cancer | Liver Neoplasms | Pancreatic Neoplasms | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Rectal Cancer | Rectal Neoplasms | Prostate Cancer | Brain Cancer | Brain Tumor | Bladder Cancer | Liver Metastases | T... and other conditions

United States, Netherlands, Germany, Canada, Denmark, United Kingdom, Australia, Belgium, Italy
Maastricht Radiation Oncology
Maastricht University Medical Center

Recruiting

Effect of stRess and exeRcize on the Outcome After Chemo-Radiation (ERROR)

Glioblastoma (GBM)

Netherlands
Vastra Gotaland Region

Recruiting

Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion (NivoILP)

Melanoma | In-Transit Metastasis

Sweden, Netherlands
University Medical Center Groningen

Completed

Detection of PitNET Tissue During TSS Using Bevacizumab-800CW (DEPARTURE)

Pituitary Adenoma | Pituitary Tumor | Pituitary Macroadenoma

Netherlands
University Medical Center Groningen

Completed

Pembrolizumab-PET Imaging

Melanoma | Non-small Cell Lung Cancer

Netherlands
Amsterdam UMC, location VUmc

Recruiting

Function and Composition of Regulatory B Cells in Participants With Glioblastoma (GBMdexaB)

Glioblastoma, Adult

Netherlands
Amsterdam UMC, location VUmc

Unknown

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Cancer | High-grade Glioma

Netherlands
Erasmus Medical Center
Stichting Coolsingel

Unknown

Intraoperative Ultrasound Guided Glioma Surgery; a Randomised, Controlled Trial. (US-GLIOMA)

Glioma

Netherlands
Novartis Pharmaceuticals

Completed

A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors

Solid Tumors

Netherlands, Spain, United Kingdom, United States, Belgium
The Netherlands Cancer Institute
Lustgarten Foundation

Recruiting

Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers (SHERPA)

Colorectal Cancer | Pancreatic Cancer | Non-small Cell Lung Cancer | KRAS Mutation-Related Tumors

Netherlands
Maastricht University Medical Center

Completed

Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors (RACING)

Glioblastoma Multiforme

Netherlands, Belgium
European Organisation for Research and Treatment...

Completed

Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery

Brain and Central Nervous System Tumors

Netherlands, Germany, Italy, France, Austria, Canada
University of Leicester

Unknown

Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma

Brain and Central Nervous System Tumors

United Kingdom, Belgium, Germany, Netherlands, France, Sweden, Italy, Spain
University Medical Center Groningen

Recruiting

Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck (REFLECT)

Oropharynx Cancer | Unknown Primary Tumors

Netherlands
University Medical Center Groningen
Radboud University Medical Center; Maastricht University Medical Center; UMC... and other collaborators

Recruiting

Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield (SERENDIPITY)

Adrenocortical Carcinoma | Adrenal Incidentaloma

Netherlands
University Medical Center Groningen

Not yet recruiting

Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors

Pituitary Tumor | Visual Fields Hemianopsia

Netherlands
Maastricht Radiation Oncology

Withdrawn

Re-irradiation of High Grade Gliomas: a Quality of Life Study

Glioblastoma Multiforme | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma

Netherlands
Novartis Pharmaceuticals

Recruiting

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Glioblastoma Multiforme | Gastroesophageal Adenocarcinoma | Pancreatic Ductal Adenocarcinoma

Netherlands, Spain, Israel, United States, Switzerland
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function

Advanced Solid Tumors

Switzerland, Sweden, Netherlands, United States, United Kingdom
The Netherlands Cancer Institute
Bristol-Myers Squibb

Active, not recruiting

Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN-neo)

Malignant Melanoma Stage III

Austria, Netherlands, Australia, Sweden
Boehringer Ingelheim

Recruiting

A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Melanoma | Non-small Cell Lung Cancer (NSCLC) | Carcinoma, Squamous Cell of Head and Neck (HNSCC)

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Tapestry: Addition of TGF-β and PDL-1 Inhibition to Definitive Chemoradiation in Esophageal Squamous Cell Carcinoma (TAPESTRY)

Neoplasm, Esophageal | Neoplasm, Esophagus | Malignant Esophagus Tumor

Netherlands
European Organisation for Research and Treatment...

Completed

Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma

Brain and Central Nervous System Tumors

France, Australia, United Kingdom, Germany, Switzerland, Netherlands, Spain
Universitätsklinikum Hamburg-Eppendorf
Deutsche Kinderkrebsstiftung

Active, not recruiting

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Brain Tumors

Germany, Denmark, United Kingdom, Belgium, Poland, Ireland, Austria, Italy, Czechia, France, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland
Novartis Pharmaceuticals

Terminated

Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET (COOPERATE-2)

Islet Cell Tumor

France, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
M.E. van Linde
Massachusetts General Hospital

Unknown

Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma) (HUTMZ)

Glioma | Glioblastoma

Netherlands
Tilburg University

Completed

Effects of Exercise on Cognitive Function in Glioma Patients

Low Grade Glioma of Brain | Anaplastic Glioma of Brain

Netherlands
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Terminated

Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction (VERITAS)

Very High Risk Neuroblastoma

Italy, Austria, France, Netherlands, Spain
Nuvalent Inc.

Recruiting

A Study of NVL-520 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Metastatic Solid Tumor | Locally Advanced Solid Tumor

Canada, United States, Korea, Republic of, Taiwan, Japan, Spain, Australia, Belgium, United Kingdom, France, Italy, Netherlands, Singapore, Germany
Navire Pharma Inc., a BridgeBio company
Amgen

Recruiting

SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation (Argonaut)

Non Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLC

Spain, Australia, France, Denmark, Greece, Italy, Netherlands
Maastricht Radiation Oncology

Active, not recruiting

The Head and Neck Tumor Biobank

Head and Neck Squamous Cell Carcinoma

Netherlands
Bristol-Myers Squibb

Completed

An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab

Malignant Solid Tumor

United States, France, Italy, Australia, Canada, Germany, Netherlands
Maastricht Radiation Oncology
Heidelberg University; University of Giessen; University Medical Center Nijmegen and other collaborators

Completed

ROCOCO - Low Grade Glioma - Planning Study (ROCOCO LGG)

Low Grade Glioma

Germany, Netherlands
AbbVie (prior sponsor, Abbott)

Completed

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Primary Peritoneal Cancer | Fallopian Tube | Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian

Netherlands
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

Solid Tumors

Belgium, Denmark, Spain, Canada, Netherlands, Poland
Kartos Therapeutics, Inc.

Recruiting

Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma

Merkel Cell Carcinoma

United States, Netherlands, Korea, Republic of, France, Germany, Spain, Canada, Italy, Australia, Brazil

Clinical Trials on Experimental Tumor in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations